nach oben

Erschienen in:

11.12.2019 | Review Article

Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis

verfasst von: Seyed-Mehdi Hashemi, Hosein Rafiemanesh, Tayebe Aghamohammadi, Mahin Badakhsh, Mehrbanoo Amirshahi, Mahdieh Sari, Niaz Behnamfar, Kamran Roudini

Erschienen in: Breast Cancer | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to determine the prevalence of anxiety among breast cancer patients. In April 2019, three electronic databases (PubMed, Web of Science, and Scopus) were searched from January, 2000 to March, 2019. Key words included were as follows: breast neoplasm, prevalence, and anxiety. A total of 36 studies that included 16,298 breast cancer patients between 2000 and 2018 were enrolled in the study. The prevalence of anxiety among breast cancer patients was 41.9% [(CI: 95%): 30.7, 53.2]. The prevalence of anxiety among patients in Mediterranean countries was higher. The study showed a high level of anxiety among breast cancer patients, indicating the importance of psychological factors as well as physical in breast cancer patients.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

Bultz BD, Carlson LE. Emotional distress: the sixth vital sign—future directions in cancer care. Psycho-oncology. 2006;15(2):93–5.PubMedCrossRef

Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry (Abingdon, England). 2017;29(5):389–402.CrossRef

Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Wain G. Breast cancer survivors' supportive care needs 2–10 years after diagnosis. Support Care Cancer. 2007;15(5):515–23.PubMedCrossRef

Morasso G, Costantini M, Viterbori P, Bonci F, Del Mastro L, Musso M, et al. Predicting mood disorders in breast cancer patients. Eur J Cancer (Oxford, England: 1990). 2001;37(2):216–23.

Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721–32.PubMedCrossRef

Forsythe LP, Kent EE, Weaver KE, Buchanan N, Hawkins NA, Rodriguez JL, et al. Receipt of psychosocial care among cancer survivors in the United States. J Clin Oncol. 2013;31(16):1961–9.PubMedPubMedCentralCrossRef

World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993.

Association AP. Diagnostic and statistical manual of mental disorders. BMC Med. 2013;17:133–7.

10.

Evans DL, Foa EB, Gur RE, Hendin H, O'Brien CP, Seligman ME, et al. Treating and preventing adolescent mental health disorders: what we know and what we don't know. UK: Oxford University Press; 2005.CrossRef

11.

Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ (Clin Res Ed). 2018;361:k1415.CrossRef

12.

Stark DPH, House A. Anxiety in cancer patients. Br J Cancer. 2000;83(10):1261.PubMedPubMedCentralCrossRef

13.

Hall A, A’hern R, Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer. 1999;35(1):79–85.PubMedCrossRef

14.

Trask PC, Esper P, Riba M, Redman B. Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. J Clin Oncol. 2000;18(11):2316–26.PubMedCrossRef

15.

Milligan F, Martinez F, Aal SHMA, Ahmed SA, Joby B, Matalam JS, et al. Assessing anxiety and depression in cancer patients. Br J Nurs. 2018;27(10):S18–S23.PubMedCrossRef

16.

Bergerot CD, Laros JA, Araujo TCCFd. Assessment of anxiety and depression in cancer patients: a psychometric comparison. Psico-USF. 2014;19(2):187–97.CrossRef

17.

Rodgers J, Martin CR, Morse RC, Kendell K, Verrill M. An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer. Health Qual Life Outcomes. 2005;3(1):41.PubMedPubMedCentralCrossRef

18.

Schreier AM, Williams SA, editors. Anxiety and quality of life of women who received radiation or chemotherapy for breast cancer. Oncology nursing forum. Pennsylvania: Oncology Nursing Society; 2004.

19.

Aerts P, De Vries J, Van der Steeg A, Roukema J. The relationship between morbidity after axillary surgery and long-term quality of life in breast cancer patients: the role of anxiety. Eur J Surg Oncol (EJSO). 2011;37(4):344–9.PubMedCrossRef

20.

Charalambous A, Kaite CP, Charalambous M, Tistsi T, Kouta C. The effects on anxiety and quality of life of breast cancer patients following completion of the first cycle of chemotherapy. SAGE Open Med. 2017;5:2050312117717507.PubMedPubMedCentralCrossRef

21.

Lou Z, Li Y, Yang Y, Wang L, Yang J. Affects of anxiety and depression on health-related quality of life among patients with benign breast lumps diagnosed via ultrasonography in China. Int J Environ Res Public Health. 2015;12(9):10587–601.PubMedPubMedCentralCrossRef

22.

Villar RR, Fernandez SP, Garea CC, Pillado MTS, Barreiro VB, Martin CG. Quality of life and anxiety in women with breast cancer before and after treatment. Rev Lat Am Enferm. 2017;25:e2958.CrossRef

23.

You J, Lu Q, Zvolensky MJ, Meng Z, Garcia K, Cohen L. Anxiety- and health-related quality of life among patients with breast cancer: a cross-cultural comparison of China and the United States. J Glob Oncol. 2018;4:1–9.PubMed

24.

Akel R, El Darsa H, Anouti B, Mukherji D, Temraz S, Raslan R, et al. Anxiety, depression and quality of life in breast cancer patients in the Levant. Asian Pac J Cancer Prev APJCP. 2017;18(10):2809–16.PubMed

25.

Kim JH, Paik HJ, Jung YJ, Kim DI, Jo HJ, Lee S, et al. A prospective longitudinal study about change of sleep, anxiety, depression, and quality of life in each step of breast cancer patients. Oncology. 2019;97(4):245–53.PubMedCrossRef

26.

Kyranou M, Paul SM, Dunn LB, Puntillo K, Aouizerat BE, Abrams G, et al. Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery. Eur J Oncol Nurs. 2013;17(2):190–5.PubMedCrossRef

27.

Zenger M, Glaesmer H, Hockel M, Hinz A. Pessimism predicts anxiety, depression and quality of life in female cancer patients. Jpn J Clin Oncol. 2011;41(1):87–94.PubMedCrossRef

28.

Schreier AM, Williams SA. Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer. Oncol Nurs Forum. 2004;31(1):127–30.PubMedCrossRef

29.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.PubMedCrossRef

30.

WHO. Definition of regional groupings. 2019. https://www.who.int/healthinfo/global_burden_disease/definition_regions/en/. Accessed 30 Mar 2019.

31.

Bank W. How does the World Bank classify countries? 2019. https://databank.worldbank.org/data/source/world-development-indicators. Accessed 30 Mar 2019.

32.

Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9.PubMedCrossRef

33.

Harris J, Cornelius V, Ream E, Cheevers K, Armes J. Anxiety after completion of treatment for early-stage breast cancer: a systematic review to identify candidate predictors and evaluate multivariable model development. Supp Care Cancer. 2017;25(7):2321–33.CrossRef

34.

Lim CC, Devi MK, Ang E. Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc. 2011;9(3):215–35.PubMed

35.

Maass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: a systematic review. Maturitas. 2015;82(1):100–8.PubMedCrossRef

36.

Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002;20(14):3137–48.PubMedCrossRef

37.

Tang NK, Lereya ST, Boulton H, Miller MA, Wolke D, Cappuccio FP. Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep. 2015;38(11):1751–64.PubMedPubMedCentralCrossRef

38.

Vin-Raviv N, Akinyemiju TF, Galea S, Bovbjerg DH. Depression and anxiety disorders among hospitalized women with breast cancer. PLoS ONE. 2015;10(6):e0129169.PubMedPubMedCentralCrossRef

39.

Chan CMH, Wan Ahmad WA, Yusof M, Ho GF, Krupat E. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews. Psycho‐Oncology. 2015;24(6):718–25.PubMedCrossRef

40.

Wilson KG, Dalgleish TL, Chochinov HM, Chary S, Gagnon PR, Macmillan K, et al. Mental disorders and the desire for death in patients receiving palliative care for cancer. BMJ Supp Palliat Care. 2016;6(2):170–7.CrossRef

41.

Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–74.PubMedCrossRef

42.

Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43(5):897–910.PubMedCrossRef

43.

Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605.PubMedPubMedCentralCrossRef

44.

Butow P, Price MA, Shaw JM, Turner J, Clayton JM, Grimison P, et al. Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines. Psycho-Oncology. 2015;24(9):987–1001.PubMedCrossRef

45.

Singer S, Das-Munshi J, Brähler E. Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol. 2009;21(5):925–30.PubMedCrossRef

46.

Watts S, Prescott P, Mason J, McLeod N, Lewith G. Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5(11):e007618.PubMedPubMedCentralCrossRef

47.

Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4(3):e003901.PubMedPubMedCentralCrossRef

48.

Akinyemiju TF. Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. PLoS ONE. 2012;7(11):e48834.PubMedPubMedCentralCrossRef

49.

Coughlin SS, Ekwueme DU. Breast cancer as a global health concern. Cancer Epidemiol. 2009;33(5):315–8.PubMedCrossRef

50.

Gutnik LA, Matanje-Mwagomba B, Msosa V, Mzumara S, Khondowe B, Moses A, et al. Breast cancer screening in low- and middle-income countries: a perspective from Malawi. J Glob Oncol. 2015;2(1):4–8.PubMedPubMedCentralCrossRef

51.

Ricardo-Rodrigues I, Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Jimenez-Trujillo I, Lopez de Andres A. Social disparities in access to breast and cervical cancer screening by women living in Spain. Public Health. 2015;129(7):881–8.PubMedCrossRef

52.

Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, et al. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer. 2008;113(8 Suppl):2244–56.PubMedCrossRef

53.

Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thail. 2007;90(10):2164.

54.

Montgomery GH, David D, Goldfarb AB, Silverstein JH, Weltz CR, Birk JS, et al. Sources of anticipatory distress among breast surgery patients. J Behav Med. 2003;26(2):153–64.PubMedCrossRef

55.

Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.PubMedPubMedCentral

56.

Mausbach BT, Bos T, Irwin SA. Mental health treatment dose and annual healthcare costs in patients with cancer and major depressive disorder. Health Psychol. 2018;37(11):1035–40.PubMedPubMedCentralCrossRef

57.

Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–41.PubMedPubMedCentralCrossRef

58.

Krebber A, Buffart L, Kleijn G, Riepma I, De Bree R, Leemans C, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology. 2014;23(2):121–30.PubMedCrossRef

59.

Mukherjee A, Mazumder K, Ghoshal S. Impact of different sociodemographic factors on mental health status of female cancer patients receiving chemotherapy for recurrent disease. Indian J Palliat Care. 2018;24(4):426.PubMedPubMedCentralCrossRef

60.

Anuk D, Özkan M, Kizir A, Özkan S. The characteristics and risk factors for common psychiatric disorders in patients with cancer seeking help for mental health. BMC Psychiatry. 2019;19(1):269.PubMedPubMedCentralCrossRef

61.

Beatty L, Kissane D, editors. Anxiety and depression in women with breast cancer. Cancer forum. Sydney: The Cancer Council Australia; 2017.

62.

Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2010;45(3):355–61.PubMedCrossRef

63.

Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ (Clin Res Ed). 2005;330(7493):702.CrossRef

64.

Ahmed AE, Albalawi AN, Qureshey ET, Qureshey AT, Yenugadhati N, Al-Jahdali H, et al. Psychological symptoms in adult Saudi Arabian cancer patients: prevalence and association with self-rated oral health. Breast Cancer (Dove Medical Press). 2018;10:153–9.PubMedPubMedCentral

65.

Alacacioglu A, Yavuzsen T, Dirioz M, Yilmaz U. Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands. Med Oncol (Northwood, London, England). 2009;26(4):415–9.CrossRef

66.

Alacacioglu A, Ulger E, Varol U, Yildiz I, Salman T, Bayoglu V, et al. Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-Izmir oncology group study. Asian Pac J Cancer Prev APJCP. 2014;15(24):10631–6.PubMedCrossRef

67.

Al-Zaben FN, Sehlo MG, Koenig HG. A cross-sectional study of anxiety and marital quality among women with breast cancer at a university clinic in western Saudi Arabia. Saudi Med J. 2015;36(10):1168–75.PubMedPubMedCentralCrossRef

68.

Fafouti M, Paparrigopoulos T, Zervas Y, Rabavilas A, Malamos N, Liappas I, et al. Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study. Vivo (Athens, Greece). 2010;24(5):803–10.PubMed

69.

Fatiregun OA, Olagunju AT, Erinfolami AR, Arogunmati OA, Fatiregun OA, Adeyemi JD. Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer. Breast. 2017;31:150–6.PubMedCrossRef

70.

Galloway SK, Baker M, Giglio P, Chin S, Madan A, Malcolm R, et al. Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat. 2012;2012:851276.PubMedPubMedCentral

71.

Geyikci R, Cakmak S, Demirkol ME, Uguz S. Correlation of anxiety and depression levels with attitudes towards coping with illness and sociodemographic characteristics in patients with a diagnosis of breast cancer. Dusunen Adam J Psychiatry Neurol Sci. 2018;31(3):246–57.CrossRef

72.

Guimond AJ, Massicotte E, Savard MH, Charron-Drolet J, Ruel S, Ivers H, et al. Is anxiety associated with hot flashes in women with breast cancer? Menopause. 2015;22(8):864–71.PubMedCrossRef

73.

Hartl K, Schennach R, Muller M, Engel J, Reinecker H, Sommer H, et al. Quality of life, anxiety, and oncological factors: a follow-up study of breast cancer patients. Psychosomatics. 2010;51(2):112–23.PubMedCrossRef

74.

Hassan MR, Shah SA, Ghazi HF, Mohd Mujar NM, Samsuri MF, Baharom N. Anxiety and depression among breast cancer patients in an urban setting in Malaysia. Asian Pac J Cancer Prev APJCP. 2015;16(9):4031–5.PubMedCrossRef

75.

Hill J, Holcombe C, Clark L, Boothby MRK, Hincks A, Fisher J, et al. Predictors of onset of depression and anxiety in the year after diagnosis of breast cancer. Psychol Med. 2011;41(7):1429–36.PubMedCrossRef

76.

Ho SS, So WK, Leung DY, Lai ET, Chan CW. Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: a comparative evaluation. Eur J Oncol Nurs. 2013;17(6):877–82.PubMedCrossRef

77.

Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM. The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast. 2010;19(2):84–91.PubMedCrossRef

78.

Jimenez-Fonseca P, Calderon C, Hernandez R, Cajal TRY, Mut M, Ramchandani A, et al. Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy. Clin Transl Oncol. 2018;20(11):1408–15.PubMedCrossRef

79.

Kalender M, Buyukhatipoglu H, Balakan O, Suner A, Dirier A, Sevinc A, et al. Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. J Cancer Res Ther. 2014;10(4):962–6.PubMedCrossRef

80.

Karakoyun-Celik O, Gorken I, Sahin S, Orcin E, Alanyali H, Kinay M. Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol (Northwood, London, England). 2010;27(1):108–13.CrossRef

81.

Lewis F, Merckaert I, Lienard A, Libert Y, Etienne AM, Reynaert C, et al. Anxiety and its time courses during radiotherapy for non-metastatic breast cancer: a longitudinal study. Radiother Oncol. 2014;111(2):276–80.PubMedCrossRef

82.

Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2–3):343–51.PubMedCrossRef

83.

Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thail (Chotmaihet Thangphaet). 2007;90(10):2164–74.

84.

Montazeri A, Jarvandi S, Haghighat S, Vahdani M, Sajadian A, Ebrahimi M, et al. Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Patient Educ Couns. 2001;45(3):195–8.PubMedCrossRef

85.

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, et al. Anxiety and depression in Iranian breast cancer patients before and after diagnosis. Eur J Cancer Care. 2000;9(3):151–7.CrossRef

86.

Montazeri A, Sajadian A, Ebrahimi M, Akbari ME. Depression and the use of complementary medicine among breast cancer patients. Supp Care Cancer. 2005;13(5):339–42.CrossRef

87.

Ng GC, Mohamed S, Sulaiman AH, Zainal NZ. Anxiety and depression in cancer patients: the association with religiosity and religious coping. J Relig Health. 2017;56(2):575–90.PubMedCrossRef

88.

Park EM, Gelber S, Rosenberg SM, Seah DSE, Schapira L, Come SE, et al. Anxiety and depression in young women with metastatic breast cancer: a cross-sectional study. Psychosomatics. 2018;59(3):251–8.PubMedPubMedCentralCrossRef

89.

Puigpinos-Riera R, Graells-Sans A, Serral G, Continente X, Bargallo X, Domenech M, et al. Anxiety and depression in women with breast cancer: social and clinical determinants and influence of the social network and social support (DAMA cohort). Cancer Epidemiol. 2018;55:123–9.PubMedCrossRef

90.

Reece JC, Chan YF, Herbert J, Gralow J, Fann JR. Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer. Gen Hosp Psychiatry. 2013;35(4):376–81.PubMedCrossRef

91.

Saboonchi F, Petersson LM, Wennman-Larsen A, Alexanderson K, Brannstrom R, Vaez M. Changes in caseness of anxiety and depression in breast cancer patients during the first year following surgery: patterns of transiency and severity of the distress response. Eur J Oncol Nurs. 2014;18(6):598–604.PubMedCrossRef

92.

Schleife H, Sachtleben C, Finck Barboza C, Singer S, Hinz A. Anxiety, depression, and quality of life in German ambulatory breast cancer patients. Breast Cancer. 2014;21(2):208–13.PubMedCrossRef

93.

Sharma A, Zhang JP. Depression and its predictors among breast cancer patients in Nepal. ASEAN J Psychiatry. 2015;16(1):106–15.

94.

So WK, Marsh G, Ling WM, Leung FY, Lo JC, Yeung M, et al. Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs. 2010;14(1):17–22.PubMedCrossRef

95.

Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S, et al. Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev APJCP. 2018;19(6):1661–9.PubMed

96.

Zhang J, Zhou Y, Feng Z, Xu Y, Zeng G. Longitudinal trends in anxiety, depression, and quality of life during different intermittent periods of adjuvant breast cancer chemotherapy. Cancer Nurs. 2018;41(1):62–8.PubMedCrossRef

Titel: Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis
verfasst von: Seyed-Mehdi Hashemi
Hosein Rafiemanesh
Tayebe Aghamohammadi
Mahin Badakhsh
Mehrbanoo Amirshahi
Mahdieh Sari
Niaz Behnamfar
Kamran Roudini
Publikationsdatum: 11.12.2019
Verlag: Springer Japan
Erschienen in: Breast Cancer / Ausgabe 2/2020
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI: https://doi.org/10.1007/s12282-019-01031-9

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection

Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay

Effects of a structured group intervention on obesity among breast cancer survivors

Instruments for determining clinically relevant fatigue in breast cancer patients during radiotherapy

Comparison of subjective, objective and patient-reported cosmetic outcomes between accelerated partial breast irradiation and whole breast radiotherapy: a prospective propensity score-matched pair analysis

Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie